Skip to main content
Opens in new window
NHS Wales
Health Boards
Trusts
NHS 111 Wales
Skip Navigation
Terms of use
Cymraeg
Cymraeg
All...
Search
Welsh Health Specialised Services Committee
Search
Cymraeg
Cymraeg
Menu
Home
About Us
Show Submenu For About Us
Medical Directorate
Individual Patient Funding Requests (IPFR)
Joint Committee
Show Submenu For Joint Committee
Committee Meetings and Papers
Sub Committees
Commissioning
Show Submenu For Commissioning
WHSSC Policies
Commissioned Services
Publications
Show Submenu For Publications
Annual Reports
Corporate Policies and Procedures
Directions and Regulations
Governance
Integrated Commissioning Plan 2024-2025
Reviews
Statements
Strategies and Plans
Publication Scheme
Quality Newsletter
Public Engagement/Consultation
Useful Links
Contact Us
More
Home
About Us
Show Submenu For About Us
Medical Directorate
Individual Patient Funding Requests (IPFR)
Joint Committee
Show Submenu For Joint Committee
Committee Meetings and Papers
Sub Committees
Commissioning
Show Submenu For Commissioning
WHSSC Policies
Commissioned Services
Publications
Show Submenu For Publications
Annual Reports
Corporate Policies and Procedures
Directions and Regulations
Governance
Integrated Commissioning Plan 2024-2025
Reviews
Statements
Strategies and Plans
Publication Scheme
Quality Newsletter
Public Engagement/Consultation
Useful Links
Contact Us
×
Neurosciences
NHS Wales
Health Boards
Trusts
NHS 111 Wales
Terms of use
All...
Search
Home
›
Commissioning
›
WHSSC Policies
›
Neurosciences
Neurosciences
Title
Adult Neurosurgery, Service Specification, (CP178), March 2023 (
PDF, 731Kb
)
Bevacizumab for the treatment of vestibular schwannomas in Neurofibromatosis Type 2 (now known as NF2-related vestibular schwannomatosis) (all ages) (CP254), August 2023 (
PDF, 440Kb
)
CP101, Intra-arterial adjunct devices adults and young people (aged 16 and over), Commissioning Policy, November 2024 (
PDF, 459Kb
)
CP22 Stereotactic Radiosurgery for Adults, Teenagers and Young Adults (TYA) (CP22) June 2026 (
PDF, 455Kb
)
Deep Brain Stimulation, Commissioning Policy (CP28), July 2024 (
PDF, 384Kb
)
Inherited White Matter Disorders Policy Position Statement (PP239) May 2023 (
PDF, 565Kb
)
Mechanical Thrombectomy for the treatment of acute Ischaemic Stroke, Commissioning Policy (CP168). March 2025 (
PDF, 887Kb
)
Odevixibat for Treating Progressive Familial Intrahepatic Cholestasis, Policy Position Statement, (PP249), February 2023 (
PDF, 193Kb
)
Plerixafor for stem cell mobilisation, Policy Position Statement (PP154), July 2024 (
PDF, 208Kb
)
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over, Policy Position Statement (PP267), September 2023 (
PDF, 228Kb
)
Specialised Neurological Rehabilitation, Commissioning Policy (CP140), February 2018 (
PDF, 474Kb
)
Specialised Neuropsychiatric Rehabilitation, Commissioning Policy (CP128), February 2018 (
PDF, 523Kb
)
Specialised Spinal Cord Injury Rehabilitation, Commissioning Policy (CP141), February 2018 (
PDF, 418Kb
)
SS235, Specialist Auditory Hearing Implant Service (all ages), Service Specification, November 2024 (
PDF, 684Kb
)
Transcranial magnetic resonance guided focused ultrasound (TcMRgFUS) thalamotomy for treatment of medication-refractory essential tremor for people aged 18 and over, Policy Position Statement, (PP258), August 2023 (
PDF, 298Kb
)
Vagus Nerve Stimulation for adults, young persons and children, Commissioning Policy (CP23), May 2024 (
PDF, 446Kb
)
Welsh Artificial Eye Service (WAES) (All Ages), Service Specification (CP238), December 2022 (
PDF, 453Kb
)
Previous
1
Next